Topics

PubMed Journals Articles About "2019 Sickle Cell Disease Guidelines American Society Hematology" - Page: 5 RSS

21:06 EST 27th February 2020 | BioPortfolio

2019 Sickle Cell Disease Guidelines American Society Hematology PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest 2019 Sickle Cell Disease Guidelines American Society Hematology articles that have been published worldwide.

More Information about "2019 Sickle Cell Disease Guidelines American Society Hematology" on BioPortfolio

We have published hundreds of 2019 Sickle Cell Disease Guidelines American Society Hematology news stories on BioPortfolio along with dozens of 2019 Sickle Cell Disease Guidelines American Society Hematology Clinical Trials and PubMed Articles about 2019 Sickle Cell Disease Guidelines American Society Hematology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 2019 Sickle Cell Disease Guidelines American Society Hematology Companies in our database. You can also find out about relevant 2019 Sickle Cell Disease Guidelines American Society Hematology Drugs and Medications on this site too.

Showing "2019 sickle cell disease guidelines American Society Hematology" PubMed Articles 101–125 of 63,000+

Prevalence of Bacteremia in Febrile Patients With Sickle Cell Disease: Meta-Analysis of Observational Studies.

Pneumococcal vaccination has decreased the bacteremia rate in both the general pediatric and sickle cell disease (SCD) populations. Despite this decrease, and an increasing concern for antibiotic resistance, it remains standard practice to obtain blood cultures and administer antibiotics in all febrile (>38.5°C) patients with SCD. We conducted a systematic review and meta-analysis of the available studies of the prevalence of bacteremia in febrile patients with SCD.


Neonatal Abstinence Syndrome among Infants Born to Mothers with Sickle Cell Hemoglobinopathies.

 The objective of this study is to examine risk factors for neonatal abstinence syndrome (NAS) among infants born to mothers with sickle cell hemoglobinopathies (SCH).

Cases of malaria in travellers with sickle cell disease - Chemoprophylaxis is important for this risk group.


Single cell analysis of bone marrow derived CD34+ cells from children with sickle cell disease and thalassemia.

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.

New blood pressure cut off for preeclampsia definition: 130/80 mmHg.

The classical diagnosis of preeclampsia is usually based on the fulfillment of 3 criteria: pregnancy > 20 weeks of gestation, proteinuria (2+ on dipstick or > 300 mg/24 h) and arterial hypertension ≥ 140/90 mm Hg. The current blood pressure cut off of 140/90 mm Hg was set by the American College of Obstetrics and Gynecology (ACOG)-issued practice bulletin of 2019, the 2013 Task Force and the guidelines prompted by the International Society for the Study of Hypertension in Pregnancy (ISSHP)...

Good Publication Practice in Physiology 2019.

In the following, novel developments in biomedical publishing important to all of our authors, reviewers and editors involved in the publication process at Acta Physiologica will be highlighted. Acta Physiologica's recommendations for authors focus on (a) the current implications of the revised ICMJE Guidelines, (b) the still recent European General Data Protection Regulation (GDPR) and (c) guidelines for experimental biomedical research involving animals. In addition, (d) Acta Physiologica follows the COPE...

Great American Smokeout - November 21, 2019.

The American Cancer Society's Great American Smokeout is an annual event that encourages smokers to make a plan to quit smoking (https://www.cancer.org/healthy/stay-away-from-tobacco/great-american-smokeout.html). The 44th annual Great American Smokeout will occur on November 21, 2019.

CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS

: The development of these updated clinical practice guidelines (CPG) was commissioned by the AACE, TOS, ASMBS, OMA, and ASA Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPG, algorithms, and checklists. : Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts. : New or updated topics in this CPG include: contextualization in an adiposity-based chronic disease complications-centric ...

Tuberculosis screening, testing, and treatment of U.S. health care personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.

Early season pediatric influenza B/Victoria virus infections associated with a recently emerged virus subclade - Louisiana, 2019.

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC Guidelines) a 2019 update.

The 4th version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic and treatment algorithms.

New Option for Sickle Cell Disease.

2019 Annual Meeting of the American Society for Bone and Mineral Research Orange County Convention Center, Orlando, Florida, USA September 20-23, 2019.

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial.

American Society for Pain Management Nursing Guidelines on Monitoring for Opioid-Induced Advancing Sedation and Respiratory Depression: Revisions.

This report presents up-to-date evidence and expert consensus-based revisions to the ASPMN 2011 guidelines that inform interprofessional clinical decision-making for hospitalized adults receiving opioid analgesics.

Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.

Genetic diversity in the RH genes among sickle cell disease (SCD) patients is well described but not yet extensively explored in populations of racially diverse origin. Transfusion support is complicated in patients who develop unexpected Rh antibodies. Our goal was to describe RH variation in a large cohort of Brazilian SCD patients exhibiting unexpected Rh antibodies (antibodies against RH antigens to which the patient is phenotypically positive) and to evaluate the impact of using the patient's RH genoty...

How I treat sickle cell disease with hematopoietic cell transplantation.

Sickle cell disease (SCD) leads to significant morbidity and early mortality, and hematopoietic cell transplantation (HCT) is the only widely available cure, with impacts seen on SCD-related organ dysfunction. Outcomes are excellent following matched related donor (MRD) HCT, leading to significantly expanded application of this treatment over the past decade. The majority of SCD patients lack a MRD, but outcomes following alternative donor HCT continue to improve on clinical trials. Within this framework, w...

Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy.

Morbid obesity is a barrier to kidney transplantation (KT) in patients with end-stage renal disease (ESRD). Laparoscopic sleeve gastrectomy (SG) is an increasingly considered intervention, but the safety and long-term outcomes are uncertain. We reviewed prospectively collected data on patients with ESRD and chronic kidney disease (CKD) undergoing SG from 2011 to 2018. 198 patients with ESRD and 45 patients with CKD (stages 1-4) met NIH guidelines for bariatric surgery and underwent SG. 72% and 48% achieved ...

Family Resilience From the Perspective of Caregivers of Youth With Sickle Cell Disease.

Families coping with sickle cell disease (SCD) often face heightened psychosocial risk factors, and research in pediatric SCD has often focused more on this area than resiliency factors. The aim of this study was to gain a better understanding of family resiliency in SCD based on caregiver perspectives. A secondary qualitative analysis was conducted with data from a mixed-methods study of caregivers of youth with SCD (n=22). Qualitative analyses involved coding based on 2 resiliency frameworks, organizing c...

Goal-oriented monitoring of cyclosporine is effective for graft-versus-host disease prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia major.

Graft-versus-host disease (GvHD) is an important challenge and one of the major causes of morbidity and mortality in children after hematopoietic stem cell transplantation (HSCT). Herein, we report our institution's experience of a goal-oriented Bayesian monitoring for cyclosporine (CsA) used alone as GvHD prophylaxis during the post-transplant period in pediatric patients with Thalassemia Major (TM) or Sickle Cell Anemia (SCA) undergoing HLA-matched HSCT. We also studied evolution of chimerism. Twenty-six ...

Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.

Microparticles are sub-micron vesicles possessing protein and other materials derived from the plasma membrane of their parent cells, and literature suggests that they may have a role in the pathophysiology and downstream manifestations of sickle cell disease (SCD). The contributions of red blood cells microparticles (RMP) to the pathogenic mechanisms and clinical phenotypes of SCD are largely unknown. There is a controversy as to whether the proportions of intravascular hemolysis (approximately ≤ 30% o...

Translating exercise benefits in sickle cell disease.

American Society for Bone and Mineral Research-Orthopaedic Research Society Joint Task Force Report on Cell-Based Therapies.

Cell-based therapies, defined here as the delivery of cells in vivo to treat disease, have recently gained increasing public attention as a potentially promising approach to restore structure and function to musculoskeletal tissues. Although cell-based therapy has the potential to improve the treatment of disorders of the musculoskeletal system, there is also the possibility of misuse and misrepresentation of the efficacy of such treatments. The medical literature contains anecdotal reports and research stu...

Elevated levels of circulating invariant natural killer cell subsets are skewed toward Th2-like phenotype in children with sickle cell disease.

Invariant natural killer T (iNKT) cells are being considered as potential targets for immunotherapeutic strategies in a variety of conditions including sickle cell disease (SCD). However, relatively little is known about the fate of iNKT cell subsets in children with SCD. Herein, quantitative and qualitative analyses of circulating iNKT cell subsets were carried out in 120 children in steady state and 30 healthy controls. Children with SCD displayed significantly elevated levels of circulating iNKT cell sub...


Quick Search